The authors found that BRCA1 mutation carriers had a 30% higher risk of dying than BRCA1-negative/sporadic cases (OS), but they did not find association between BRCA1 and the risk of death from breast cancer (BCSS). The gene discussed is BRCA1; the disease is breast carcinoma.